Vaccine rejection and hesitation in Turkey

Özceylan, Gökmen; Toprak, Dilek; Esen, Elif Serap

doi:10.1080/21645515.2020.1717182

Cited by 81 publications

(50 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Combining this information with the integration tardiness, we may deduct that Turkish immigrants in Germany are substantially affected by external negative factors. It was reported that 6.17% of adults in Western Turkey received no lifetime vaccination at all and anticipated a further decline in vaccination rates (32). In fact, vaccine hesitancy proportions in Turkey are growing dramatically.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy in People With Migratory Backgrounds: A Cross-Sectional Study Among Turkish- and German-Speaking Citizens in Munich

Aktürk

Linde

Hapfelmeier

et al. 2021

Preprint

View full text Add to dashboard Cite

BackgroundThis study aimed to investigate the knowledge, attitudes, behaviors, and vaccine hesitancy of people with migratory backgrounds among Turkish- and German-speaking patients in Munich regarding the COVID-19 pandemic.MethodsPrimary outcomes were the intention to get vaccinated for COVID-19 and COVID-19 knowledge levels (25 true/false items). Other variables included demographics, attitudes to COVID-19 and vaccination (7 items), and behaviors regarding COVID-19 (7 items). The attitude and behavior questions had 5-point Likert scales. Of the 10 Turkish-speaking family physicians in Munich, 6 agreed to administer Turkish or German questionnaires to consecutive patients during February 2021. Participants with either citizenship, country of origin, native language, or place of birth being non-German were categorized as “Having a migratory background.” Data from 420 respondents were analyzed.ResultsWomen constituted 41.4% (n=174), the mean age was 42.2±15.5 years, 245 (58.3%) preferred the Turkish questionnaire, 348 (82.9%) had a migratory background, and 197 (47.9%) intended to be vaccinated. The mean knowledge, attitude, and behavior scores were 21.5±3.2 (max=25), 3.7±0.8 (max=5), and 4.0±0.5 (max=5). While 42.3% (n=145) of the participants with a migratory background considered getting vaccinated, this proportion was 76.5% (n=52) for non-immigrant Germans (Chi-square=26.818, p<0.001). Non-migratory background (Odds Ratio (OR): 3.082), high attitude scores (OR: 2.877), male sex (OR: 2.185), years of schooling (OR: 1.064), and age (OR: 1.022) were positively associated with vaccination intention.ConclusionsWe suggest initiating or supporting projects run by persons or groups from inside the immigrants targeting to elaborate and change their vaccination attitudes.

show abstract

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy in People With Migratory Backgrounds: A Cross-Sectional Study Among Turkish- and German-Speaking Citizens in Munich

Aktürk

Linde

Hapfelmeier

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…With the perception that the problems may develop after vaccination and concomitant cessation of breastfeeding, families's trust in vaccination companies and vaccines may decrease. 20 The strong point of this study is trying to emphasize the relationship between rotavirus vaccine and FA. It was also to see if there was a difference between both vaccines.…”

Section: Discussionmentioning

confidence: 99%

“…With the perception that the problems may develop after vaccination and concomitant cessation of breastfeeding, families’s trust in vaccination companies and vaccines may decrease. 20 …”

Section: Discussionmentioning

confidence: 99%

May rotavirus vaccine be affect food allergy prevalence?

Karakaş

Arslan

Atalay

et al. 2020

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Incidence of food allergy (FA) during nursing period is 6-8% globally and It is reported %5,7 in Turkey. In our study, the aim is to determine whether the prevalence of food allergy (FA) increases in children vaccinated against rotavirus. The files of 681 infants who are still followed-up were retrospectively evaluated. Children who did not come to our clinic for all of their well-child follow-up visits were excluded from the study. Moreover, children diagnosed with allergy before vaccination and children with known gastrointestinal system disease were excluded from the study. The number of patients diagnosed with food allergy after being vaccinated against rotavirus was 12 (1.76%). Three children had a family history of allergy. Of 12 patients who were diagnosed after vaccination, 3 (n:104) were vaccinated with pentavalent vaccine and 9 (n:507) with monovalent vaccine. In the monovalent vaccination group, food allergy was found in 9 children (1.55%), and in the pentavalent vaccination group, food allergy was found in 3 children (2.88%). The difference between the two vaccination groups in terms of food allergy prevalence was not significant (p > .05). Although it is believed that food allergy, and even cow's milk protein allergy (CMPA) prevalence increases in infants vaccinated against rotavirus, in this study, no significant increase was observed in the prevalence of food allergy after rotavirus vaccination. Both types of vaccine had similar rates to each other.

show abstract

“…If trials and approvals are successful along this never-before-seen timeline, major logistical hurdles will remain before a vaccine can be distributed to vast populations. At this moment, public distrust in medicine and governing authorities translates to considerable vaccine hesitancy in a multitude of countries (44)(45)(46). This apprehension will likely hinder the compliance necessary to achieve broad inoculation and subsequent immunity (47).…”

Section: Discussionmentioning

confidence: 99%

“…At this moment, public distrust in medicine and governing authorities translates to considerable vaccine hesitancy in a multitude of countries. 44–46 This apprehension will likely hinder the compliance necessary to achieve broad inoculation and subsequent immunity. 47 A vaccine will be a significant triumph.…”

Section: Discussionmentioning

confidence: 99%

Rapidly self-sterilizing PPE capable of 99.9% SARS-CoV-2 deactivation in 30 seconds

Aa¹,

Izadjoo²,

Kim³

et al. 2020

Preprint

View full text Add to dashboard Cite

The Coronavirus disease 2019 (COVID-19) has created an acute worldwide demand for sustained broadband pathogen suppression in households, hospitals, and public spaces. Infections have surged past 160,000 daily new cases in the US, the highest rates yet seen during the pandemic. In response, we have created a rapid-acting, self-sterilizing PPE configurations capable of killing SARS-CoV-2 and other microbes in seconds. The highly active material destroys pathogens faster than any conventional copper configuration. The material maintains its antimicrobial efficacy over sustained use and is shelf stable. We have performed rigorous testing in accordance with guidelines from U.S. governing authorities and believe that the material could offer broad spectrum, non-selective defense against most microbes via integration into masks and other protective equipment.SummaryA novel configuration of copper offers continued fast-acting protection against viruses and bacteria, including SARS-CoV-2.

show abstract

Vaccine rejection and hesitation in Turkey

Cited by 81 publications

References 25 publications

COVID-19 Vaccine Hesitancy in People With Migratory Backgrounds: A Cross-Sectional Study Among Turkish- and German-Speaking Citizens in Munich

COVID-19 Vaccine Hesitancy in People With Migratory Backgrounds: A Cross-Sectional Study Among Turkish- and German-Speaking Citizens in Munich

May rotavirus vaccine be affect food allergy prevalence?

Rapidly self-sterilizing PPE capable of 99.9% SARS-CoV-2 deactivation in 30 seconds

Contact Info

Product

Resources

About